{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:55:47Z","timestamp":1768438547519,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.clml.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T14:50:27Z","timestamp":1470927027000},"page":"637-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides"],"prefix":"10.1016","volume":"16","author":[{"given":"Francine","family":"Foss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2016.08.009_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib2","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2016.08.009_bib3","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2016.08.009_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2016.08.009_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2005.06676.x","article-title":"Prognostic factors and prediction of prognosis by the CTCL severity index in mycosis fungoides and S\u00e9zary syndrome","volume":"153","author":"Klemke","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2016.08.009_bib6","series-title":"NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphoma, version 3","year":"2016"},{"key":"10.1016\/j.clml.2016.08.009_bib7","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1182\/blood-2011-09-379107","article-title":"Early CTCL diagnosis, a (miR)age no more?","volume":"118","author":"Mishra","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2016.08.009_bib9","first-page":"566","article-title":"Treatment of cutaneous T-cell lymphoma\/mycosis fungoides","volume":"18","author":"Parker","year":"2006","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.clml.2016.08.009_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/S\u00e9zary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2016.08.009_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archdermatol.2010.101","article-title":"Folliculotropic mycosis fungoides: single-center study and systematic review","volume":"146","author":"Lehman","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2016.08.009_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2016.08.009_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1548-5315(11)70414-4","article-title":"Mycosis fungoides and S\u00e9zary syndrome: the burden of pruritus","volume":"7","author":"Demierre","year":"2010","journal-title":"Commun Oncol"},{"key":"10.1016\/j.clml.2016.08.009_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clml.2016.08.009_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clml.2016.08.009_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.clml.2016.08.009_bib19","series-title":"Istodax (romidepsin) [package insert]","year":"2014"},{"key":"10.1016\/j.clml.2016.08.009_bib20","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2016.08.009_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10428194.2012.711829","article-title":"Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin","volume":"54","author":"Kim","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2016.08.009_bib22","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3109\/10428194.2015.1014360","article-title":"Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma","volume":"56","author":"Kim","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2016.08.009_bib23","first-page":"101754","article-title":"Clinical trials and treatment of ATL","volume":"2012","author":"Tsukasaki","year":"2012","journal-title":"Leuk Res Treat"},{"key":"10.1016\/j.clml.2016.08.009_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2013.04.001","article-title":"Biology and treatment of HTLV-1 associated T-cell lymphomas","volume":"26","author":"Tsukasaki","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2016.08.009_bib25","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1182\/blood-2009-03-210989","article-title":"Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma\/leukemia causing skin erosions","volume":"113","author":"Marneros","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib26","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1182\/blood-2009-08-236612","article-title":"Cutaneous tumor lysis syndrome in a patient with HTLV-1 adult T-cell lymphoma\/leukemia","volume":"114","author":"Bouaziz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib27","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood.V120.21.3660.3660","article-title":"Cutaneous toxicity associated with\u00a0pralatrexate in cutaneous and peripheral T-cell lymphoma","volume":"120","author":"Parker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2340\/00015555-1476","article-title":"Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series","volume":"93","author":"Mantaka","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clml.2016.08.009_bib29","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-07-202895","article-title":"How I treat mycosis fungoides and S\u00e9zary syndrome","volume":"114","author":"Prince","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.08.009_bib30","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016303834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016303834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:27:59Z","timestamp":1761870479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016303834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2152265016303834"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2016.08.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2016.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}